Generation of a TSC2 knockout embryonic stem cell line by CRISPR/ Cas9 editing

被引:0
|
作者
Zhang, Siyao [1 ,2 ]
Fan, Jiaqi [1 ,2 ]
Sun, Hairui [1 ,2 ]
Hao, Xiaoyan [1 ,2 ]
He, Yihua [2 ]
机构
[1] Capital Med Univ, Anzhen Hosp, Beijing 100029, Peoples R China
[2] Capital Med Univ, Beijing Anzhen Hosp, Maternal Fetal Med Ctr Fetal Heart Dis, Beijing 100029, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1016/j.scr.2024.103399
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Tuberous Sclerosis Complex (TSC) is a severe developmental disorder with various clinical effects, primarily caused by TSC2 gene mutations, often involving loss of function(Henske,et al., 2016).To explore role of TSC2 in human heart development, we successfully developed a TSC2 knockout (TSC2-/-) human embryonic stem cells (hESCs) line using CRISPR/Cas9 gene editing. This TSC2-/- hESC line maintained a normal karyotype, expressed pluripotency markers strongly, and could differentiate into all three germ layers in vivo. This cell line will be a valuable tool for future research on the role of TSC2 in heart development.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Generation of PARP1 gene knockout human embryonic stem cell line using CRISPR/Cas9
    Li, Yuhang
    Li, Jinbing
    Zhou, Tiancheng
    Pan, Guangjin
    Huang, Ke
    STEM CELL RESEARCH, 2021, 53
  • [22] Generation of GADD45A gene knockout human embryonic stem cell line using CRISPR/Cas9
    Li, Jinbing
    Li, Yuhang
    Zhan, Xiao-Yong
    Ran, Xinru
    Tse, Hung-Fat
    Dang, Shiying
    Nie, Yichu
    Huang, Ke
    STEM CELL RESEARCH, 2020, 49
  • [23] Generation of a FMR1 homozygous knockout human embryonic stem cell line (WAe009-A-16) by CRISPR/Cas9 editing
    Giri, Subhajit
    Purushottam, Meera
    Viswanath, Biju
    Muddashetty, Ravi S.
    STEM CELL RESEARCH, 2019, 39
  • [24] Generation of a TBX5 homozygous knockout embryonic stem cell line (WAe009-A-45) by CRISPR/Cas9 genome editing
    Zhao, Tiantian
    Bai, Rui
    Wu, Fujian
    Lu, Wen-Jing
    Zhang, Jun
    STEM CELL RESEARCH, 2021, 51
  • [25] Generation of a homozygous GRIN2A gene knockout human embryonic stem cell line using CRISPR/Cas9 system
    Luo, Xian
    Yang, Kaiming
    Jiang, Meiling
    Chen, Tao
    Chi, Yue
    Ma, Bingxiu
    Lai, Liangxue
    Zou, Qingjian
    STEM CELL RESEARCH, 2023, 69
  • [26] Generation of a heterozygous SOX10 knockout human embryonic stem cell line using CRISPR/Cas9 technology
    Wang, Tao
    Zhang, Jinli
    Liu, Jia
    Lai, Xingqiang
    STEM CELL RESEARCH, 2021, 57
  • [27] Generation of a TIMP3 knockout stem cell line via CRISPR/Cas9 system
    Yi, Tong
    Liu, Jingjing
    Zhang, Siyao
    He, Yihua
    Han, Jiancheng
    STEM CELL RESEARCH, 2023, 67
  • [28] Generation of a homozygous ZBTB7A knockout human induced pluripotent stem line by CRISPR/Cas9 editing
    Chen, Diyu
    Song, Bing
    Cheng, Yi
    Zhu, Lifen
    Lu, Dian
    Liu, Nengqing
    Yang, Yinghong
    Sun, Xiaofang
    STEM CELL RESEARCH, 2021, 55
  • [29] Generation of a homozygous S100A1 knockout human embryonic stem cell line (WAe009-A-73) by the CRISPR/Cas9 editing system
    Zhang, Shuai
    Guo, Tianwei
    Song, Yuanxiu
    Jiang, Mengqi
    Jiang, Youxu
    Dong, Tao
    Zhang, Siyao
    Wang, Hong
    Hou, Xiaotong
    STEM CELL RESEARCH, 2022, 59
  • [30] Generation of a COL1A2 homozygous knockout stem cell line via CRISPR/Cas9 system
    Ma, Shuhong
    Saleem, Amina
    Li, Xiaowei
    Lu, Wen-Jing
    Jiang, Hongfeng
    STEM CELL RESEARCH, 2022, 59